Understanding the challenges

Regardless of the severity, hallucinations or delusions can bring about a new set of challenges, impacting people with Parkinson’s disease (PD), their caregivers, and their loved ones.

Common Challenges

MORE THAN MOTOR SYMPTOMS

People who develop non-motor symptoms like hallucinations or delusions often have to deal with a broader set of challenges and more limitations to their activities of daily life.

CHANGES AT HOME

Hallucinations and delusions can increase the distress of people with Parkinson’s and the people who care for them.

LOSING TOUCH WITH REALITY

As hallucinations or delusions progress, the people who experience them may lose the ability to identify whether or not what they’re experiencing is real.

EMOTIONAL CHALLENGES

It’s not surprising that Parkinson’s disease hallucinations and delusions can also present emotional issues for everyone involved. PD-related hallucinations and delusions can cause emotional distress and increased burden for the caregiver. It’s important to remember that these symptoms are part of the disease.

Joe & Mariann

Joe experiences hallucinations and delusions related to Parkinson’s disease. In this video, Joe talks about how these experiences have affected him, and that he’s begun speaking to his healthcare provider to address them.

"The most important thing about sharing the story is I have a chance to talk about Parkinson’s. You can get through adversity, you just have to work a little bit harder."

Joe J.

Personal Stories of Joe & Mariann Video, Thumbnail

Individual results may vary.

Hear real stories about living with PD-related hallucinations and delusions

Learn about NUPLAZID^® (pimavanserin)

WARNING: INCREASED RISK OF DEATH IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS.

Medicines like NUPLAZID can raise the risk of death in elderly people who have lost touch with reality (psychosis) due to confusion and memory loss (dementia). NUPLAZID is not approved for the treatment of patients with dementia-related psychosis unrelated to the hallucinations and delusions associated with Parkinson’s disease psychosis.

WARNING: INCREASED RISK OF DEATH IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS

Medicines like NUPLAZID can raise the risk of death in elderly people who have lost touch with reality (psychosis) due to confusion and memory loss (dementia).
NUPLAZID is not approved for the treatment of patients with dementia-related psychosis unrelated to the hallucinations and delusions associated with Parkinson’s disease psychosis.

Do not take NUPLAZID if you have had an allergic reaction to any of the ingredients in NUPLAZID. Allergic reactions have included rash, hives, swelling of the tongue, mouth, lips, or face, throat tightness, and shortness of breath.

NUPLAZID may cause serious side effects including:
- QT Interval Prolongation: NUPLAZID may increase the risk of changes to your heart rhythm. This risk may increase if NUPLAZID is taken with certain other medications known to prolong the QT interval. Tell your healthcare provider about all the medicines you take or have recently taken.
- Do not take NUPLAZID if you have certain heart conditions that change your heart rhythm. It is important to talk to your healthcare provider about this possible side effect. Call your healthcare provider if you feel a change in your heartbeat.

Tell your healthcare provider about all the medicines you take. Other medicines may affect how NUPLAZID works. Some medicines should not be taken with NUPLAZID. Your healthcare provider can tell you if it is safe to take NUPLAZID with your other medicines. Do not start or stop any medicines while taking NUPLAZID without talking to your healthcare provider first.
The most common side effects of NUPLAZID include swelling in the legs or arms, nausea, confusion, hallucination, constipation, and changes to normal walking. These are not all the possible side effects of NUPLAZID. For more information, ask your healthcare provider about this medicine.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1‑800‑FDA‑1088. You can also call ACADIA Pharmaceuticals Inc. at 1‑844‑4ACADIA (1‑844‑422‑2342).

Indication

NUPLAZID is a prescription medicine used to treat hallucinations and delusions associated with Parkinson’s disease psychosis.

Dosage and Administration

The recommended dose of NUPLAZID is one 34 mg capsule once per day, taken by mouth.

NUPLAZID is available as 34 mg capsules and 10 mg tablets.

Please read the full Prescribing Information, including Boxed WARNING.

This website is intended for use by US residents.